维普中文期刊产品整合服务
29篇 您的检索式:作者名="Michael Tr"
    题名 作者 年代 出处 被引量
1Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques显示文摘AIM:To compare ultrasound-based acoustic structure quantification(ASQ) with established non-invasive techniques for grading and staging fatty liver disease.METHODS:Type 2 diabetic patients at risk of nonalcoholic fatty liver disease(n = 50) and healthy volunteers(n = 20) were evaluated using laboratory analysis and anthropometric measurements, transient elastography(TE), controlled attenuation parameter(CAP), proton magnetic resonance spectroscopy(1H-MRS; only available for the diabetic cohort), and ASQ.ASQ parameters mode, average and focal disturbance(FD) ratio were compared with:(1) the extent of liver fibrosis estimated from TE and nonalcoholic fatty liver disease(NAFLD) fibrosis scores; and(2) the amount of steatosis, which was classified according to CAP values.RESULTS:Forty-seven diabetic patients(age 67.0±8.6 years;body mass index 29.4±4.5 kg/m2)with reliable CAP measurements and all controls(age 26.5±3.2 years;body mass index 22.0±2.7 kg/m2)were included in the analysis.All ASQ parameters showed differences between healthy controls and diabetic patients(P<0.001,respectively).The ASQ FD ratio(logarithmic)correlated with the CAP(r=-0.81,P<0.001)and 1H-MRS(r=-0.43,P=0.004)results.The FD ratio[CAP<250 d B/m:107(102-109),CAP between 250 and 300 d B/m:106(102-114);CAP between 300 and 350 d B/m:105(100-112),CAP≥350 d B/m:102(99-108)]as well as mode and average parameters,were reduced in cases with advanced steatosis(ANOVA P<0.05).However,none of the ASQ parameters showed a significant difference in patients with advanced fibrosis,as determined by TE and the NAFLD fibrosis score(P>0.08,respectively).CONCLUSION:ASQ parameters correlate with steatosis,but not with fibrosis in fatty liver disease.Steatosis estimation with ASQ should be further evaluated in biopsy-controlled studies.Thomas Karlas Joachim Berger Nikita Garnov Franziska Lindner Harald Busse Nicolas Linder Alexander Schaudinn Bettina Relke Rima Chakaroun Michael Trltzsch Johannes Wiegand Volker Keim 2015World Journal of Gastroenterology2015,21,16:9
2Acoustic radiation force impulse imaging (ARFI) for non-invasive detection of liver fibrosis: examination standards and evaluation of interlobe differences in healthy subjects and chronic liver disease显示文摘Thomas Karlas Cornelia Pfrepper Johannes Wiegand Christian Wittekind Marie Neuschulz Joachim M?ssner Thomas Berg Michael Tr?ltzsch Volker Keim 2011Scandinavian Journal of Gastroenterology2011,,12:4
3Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores显示文摘Thomas Karlas Maria Hempel Michael Tr?ltzsch Dominik Huster Peter Günther Hannelore Tenckhoff Joachim M?ssner Thomas Berg Volker Keim Johannes Wiegand 2012Scandinavian Journal of Gastroenterology2012,,11:2
4Developing pharmaceutical care plans for desired outcomes显示文摘Dennis JM Bruce CC Michael TR 1996J Am Pharm Assoc1996,36,4:1
5Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence显示文摘Akial NV Michael TD Pedro TR 2004Gynecol Oncol2004,93,:1
6Clinical, angiographic, and procedural predictors of periprocedural complications during chronic total occlusion percutaneous coronary intervention 显示文摘Patel VG Michael Tr Mogabgab O 2014J In- vasive Cardiol2014,26,3:1
7Developing pharmaceutical care plans for desired utcomes显示文摘Dennis JM Bruce CC Michael TR 1996J Am Pharrn Assoc1996,36,4:1
8Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas显示文摘Michael Pfreundschuh Lorenz Trümper Marita Kloess 2004Blood2004,104,:1
9Developing pharmaceutical care plans for desired outcomes显示文摘 Bruce CC Michael TR 1996J Am Pharm Assoc1996,36,4:1
10Bacterial endophthalmttis: Therapeutic challenges and host-pathogen intemctions显示文摘Michelle CC Michael SG Meredith G Raniyah TR Brandt JW Andrea LM 2007Pro Re tinal E vie Res2007,26,:1
11Developing pharmaceutical care plans fordesired outcomes 显示文摘Dennis JIII Brace CC Michael TR 1996JAm PharmAssoc1996,36,4:1
12The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity 显示文摘John TR Michael CA Chris JM 2007Neuron2007,54,:1
13Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience显示文摘 Michael JM Scott TR 1997Am Heart J1997,133,11:1
14CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group显示文摘Michael Pfreundschuh Lorenz Trümper Anders ?sterborg Ruth Pettengell Marek Trneny Kevin Imrie David Ma Devinder Gill Jan Walewski Pier-Luigi Zinzani Rolf Stahel Stein Kvaloy Ofer Shpilberg Ulrich Jaeger Mads Hansen Tuula Lehtinen Armando López-Guillermo C 2006Lancet Oncology2006,,5:1
15Treatment of medically- and surgically refractory angina pectoriswith high thoracic epidural an- algesia:initial clinical experience显示文摘Grambling-Babb P Michael JM Scott TR 1997Am Heart J1997,133,6:1
16Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience显示文摘Grambling-Babb P Michael JM Scott TR 1997Am Heart J1997,133,:1
17CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group显示文摘Michael Pfreundschuh Evelyn Kuhnt Lorenz Trümper Anders ?sterborg Marek Trneny Lois Shepherd Devinder S Gill Jan Walewski Ruth Pettengell Ulrich Jaeger Pier-Luigi Zinzani Ofer Shpilberg Stein Kvaloy Peter de Nully Brown Rolf Stahel Noel Milpied Armando 2011Lancet Oncology2011,,11:1
18Growth characteristics and imaging properties of the morris hepatoma 3924a in ACI rats: A suitable model for transarterial chemoembolization显示文摘Jochen Trübenbach Florian Graepler Philippe L Pereira Peter Ruck Ulrich Lauer Michael Gregor Claus-D. Claussen Peter E. Huppert 2000Cardiovascular and Interventional Radiology2000,,3:1
19A phase I study of Adp53(INGN 201; ADVEXIN) for patients with platinum-and paclitaxel-resistant epithelial ovarian cancer显示文摘Judith KW Diane CB Jacalyn BG Michael D Lois R Pedro TR 2004Gynecol Oncol2004,94,:1
20Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease显示文摘Michael Fernandez Eric Trépo Delphine Degré Thierry Gustot Laurine Verset Pieter Demetter Jacques Devière Michael Adler Christophe Moreno 2015European Journal of Gastroenterology & Hepatology2015,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费